Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.78−0.09 (-1.85%)
Close on Nov 18, 2026Market cap $789.85MP/E 6.2Yield –
Ironwood Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Ironwood Pharmaceuticals's price to book ratio was 2.4× on Jul 31, 2023, against 3.4× a year earlier. Over the last 5 years it ranged from 2.3× to 312.4×, with a median of 9.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jul 31, 2023 | 2.4× | −0.8 |
| 2022 | Dec 30, 2022 | 3.2× | −0.1 |
| 2021 | Dec 31, 2021 | 3.3× | −305.5 |
| 2020 | Dec 31, 2020 | 308.8× | +300.2 |
| 2017 | Jan 31, 2017 | 8.7× | −0.5 |
| 2016 | Dec 30, 2016 | 9.2× | −3.0 |
| 2015 | Dec 31, 2015 | 12.2× | −6.5 |
| 2014 | Dec 31, 2014 | 18.7× | +7.4 |
| 2013 | Dec 31, 2013 | 11.3× | +4.9 |
| 2012 | Dec 31, 2012 | 6.5× | −2.7 |
| 2011 | Jul 29, 2011 | 9.2× | – |
See a number that looks wrong?